肝损伤
药理学
磺胺吡啶
结肠炎
炎症
超氧化物歧化酶
氧化应激
胆汁淤积
医学
胆汁酸
下调和上调
一氧化氮
溃疡性结肠炎
化学
内科学
生物化学
基因
疾病
作者
Lixia Li,Yingjie Wang,Ling Zhao,Gang Ye,Fei Shi,Yinglun Li,Yuanfeng Zou,Xu Song,Xinghong Zhao,Zhongqiong Yin,Xueyuan Wu,Wen Li,Huaqiao Tang
标识
DOI:10.1016/j.jep.2022.115682
摘要
SanHuang XieXin decoction (SXD) is a widely applicated traditional Chinese medicine (TCM) with a significant gut-liver axis regulation effect.To evaluate the therapeutic effect and elucidate the possible underlying molecular mechanisms of SXD on liver damage secondary to ulcerative colitis (UC) in mice.A model of liver damage secondary to UC was induced by drinking 5% dextran sodium sulfate (DSS) in mice. These mice were treated with one of three doses of SXD or sulfasalazine (SASP), then liver samples were collected and tested.The results reveal that SXD treatment reduced liver cells swelling, and inhibited the accumulation of the hepatic-pro-inflammatory cytokines IL-1β and tumor necrosis factor-α (TNF-α) in mice with colitis. In addition, SXD reduced the production of nitric oxide (NO) and malondialdehyde (MDA), and increased the activities of superoxide dismutase (SOD). In inflammation regulating, SXD significantly down regulated the protein expression of MyD88 and p-Iκα, but upregulated Iκα. In bile acid metabolism regulating, SXD significantly down regulated the protein expression of FXR, MRP2, BESP and SHP. Therefore, SXD treatment can regulate the TLR4-NF-κB and bile acid metabolism pathways to alleviate liver inflammation and cholestasis.These results demonstrate that SXD is a potential alternative therapeutic medicine for the treatment of liver damage secondary to colitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI